X

PT-141 / 10 mg

23,00 

PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist supplied in lyophilized powder form for laboratory research. Commonly investigated in studies of melanocortin signaling and neuroendocrine response mechanisms. Delivered as a 10 mg sterile lyophilized preparation in a sealed research vial.

In stock

Description

Peptide for libido and sexual function research

Product overview

PT-141 (Bremelanotide) is a synthetic peptide derived from the melanocortin pathway and is of high interest in research related to libido, arousal, and sexual function. Unlike PDE-5 inhibitors, PT-141 acts centrally by stimulating melanocortin receptors, making it relevant for studies exploring neural pathways of sexual behavior in both males and females.

Key benefits (anecdotal & research-based)

Studied for enhancing libido and sexual desire in males and females.
Investigated for improving erectile function through central melanocortin pathways.
Potential to increase sexual responsiveness independent of vascular mechanisms.
Anecdotal reports suggest increased arousal and sexual motivation.
Useful in research focused on hypoactive sexual desire disorders.

Product characteristics

Purity: ≥98% (HPLC-tested)
Appearance: Lyophilized white/off-white powder
Molecular formula: C50H68N14O10
Molecular weight: 1025.2
Sequence: Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-OH ChemicalBridge Asp2-Lys7
Storage: store lyophilized powder at -20°C, protect from light and moisture. Reconstituted solution should be kept at 2–8°C and used within a short period.

Why choose our PT-141?

≥ 98% purity verified by HPLC.
Produced in GMP-compliant facilities under strict QC protocols.
Each batch carefully lab tested after production (you can find Certificate of Analysis under product pictures).
Freeze-dried (lyophilized) for maximum stability and extended shelf life.
Sealed in sterile vials, ready for reconstitution.

Suggested use

In research environments, PT-141 is typically investigated via subcutaneous administration. Common protocols (based on anecdotal reports):
1-2 mg per administration.
Protocol frequency: Used intermittently based on experimental design.
Onset window: Research suggests activity begins 1–4 hours post-administration.
Must be reconstituted with 2-3 ml of bacteriostatic water before use.

NOTE: This is for educational reference only and does not constitute medical advice.

Disclaimer:
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.

Reviews

There are no reviews yet.

Be the first to review “PT-141 / 10 mg”

Your email address will not be published. Required fields are marked *

Related products